News
The European agency has started a review of sodium oxybate to assess its use to treat alcohol withdrawal syndrome and support ...
The European Medicines Agency has begun a review of medicines to treat alcohol dependency that contain sodium oxybate, it said on Friday, following concerns of potential misuse or abuse. The regulator ...
The dapivirine ring was originally approved in July 2020 to reduce the risk for HIV-1 infection in women 18 years and older ...
11h
GlobalData on MSNMadrigal poised to enter European MASH market after CHMP endorsementRevenue for Madrigal’s Rezdiffra, already approved in the US, is expected to skyrocket over the coming decade.
The European Union's medicine regulator has begun a review of some medicines that contain sodium oxybate and are used to treat alcohol withdrawal syndrome, it said on Friday. Sodium oxybate is an ...
In a first for the bloc, Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing ...
GSK (LSE:GSK) announced that the European Medicines Agency accepted its regulatory application to expand the use of its RSV ...
A comprehensive analysis conducted by public health experts at Novartis Romania reveals that Romanian patients may wait, on ...
Patients taking weight-loss medicines such as Novo Nordisk A/S’s Ozempic and Wegovy are at risk of developing an eye condition that can cause vision loss, according to Europe’s drug regulator.
The Patented Medicine Prices Review Board (PMPRB) published the 9th edition of its annual Meds Entry Watch report today. Like last year, the analysis finds that the number of new medicines launched in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results